New Vic virus trial could hasten recovery

By Benita Kolovos
Updated August 8 2020 - 8:31am, first published 8:29am
Favipiravir was originally developed to treat people with influenza.
Favipiravir was originally developed to treat people with influenza.

Melbourne researchers are looking for people infected with COVID-19 to participate in a trial of an antiviral medication that could speed up their recovery.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Kempsey news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.